
Amicus Therapeutics Inc (FOLD) poses a Brand-New Opportunity for Investors with beta value of 0.52
Amicus Therapeutics Inc (NASDAQ: FOLD) started the day on Thursday, with a price decrease of -1.87% at $6.3, before settling in for the price of
Amicus Therapeutics Inc (NASDAQ: FOLD) started the day on Thursday, with a price decrease of -1.87% at $6.3, before settling in for the price of
Witnessing the stock’s movement on the chart, on Wednesday, Amicus Therapeutics Inc (NASDAQ: FOLD) had a quiet start as it plunged -0.88% to $5.66, before
On Monday, Amicus Therapeutics Inc (NASDAQ: FOLD) was 0.33% up from the session before settling in for the closing price of $6.03. A 52-week range
Amicus Therapeutics Inc (NASDAQ: FOLD) kicked off on Friday, up 3.36% from the previous trading day, before settling in for the closing price of $5.96.
Witnessing the stock’s movement on the chart, on Wednesday, Amicus Therapeutics Inc (NASDAQ: FOLD) had a quiet start as it plunged -2.56% to $6.10, before
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.